Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 84

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 84
---
-------------------------------------------------------------------------------------------------------------------------------------|
| · | our definitive proxy statement on Schedule 14A filed with the SEC on April 18, 2025;                                                                                                                                                                                 |
| · | our Current Reports on Form 8-K filed with the SEC on May 13, 2025, June 5, 2025, June 27, 2025 and August 13, 2025; and                                                                                                                                             |
| · | the description of our common stock, which is registered under Section 12 of the Exchange Act, in our registration statement on Form 8-A, filed with the SEC on July 8, 2015, including any amendment or reports filed for the purpose of updating such description. |

In addition,
all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of
the offering (excluding any information furnished rather than filed) shall be deemed to be incorporated by reference into this prospectus.

We will
provide to each person, including any beneficial owners, to whom a prospectus is delivered, a copy of any or all of the reports or documents
that have been incorporated by reference in the prospectus contained in the registration statement but not delivered with the prospectus.
We will provide these reports or documents upon written or oral request at no cost to the requester. You should direct any written requests
for documents to:

<div align='center'>Aethlon Medical, Inc.

11555 Sorrento Valley Road,
Suite 203

San Diego, California 92121

Telephone: (619) 941-0360</div>

You also
may access these filings through the SEC website at www.sec.gov or on our website at www.aethlonmedical.com. Information contained on
or accessible through our website is not a part of this prospectus or the registration statement of which it forms a part, and the inclusion
of our website address in this prospectus is an inactive textual reference only.

In accordance
with Rule 412 of the Securities Act, (i) any statement contained in a document incorporated by reference herein shall be deemed modified
or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to
be incorporated by reference herein modifies or supersedes such statement, and (ii) any statement contained in a document that is
deemed to be incorporated by reference herein after the date of this prospectus may modify or replace